Published in J Mol Diagn on June 30, 2011
Validation of standards for quantitative assessment of JAK2 c.1849G>T (p.V617F) allele burden analysis in clinical samples. Genet Test Mol Biomarkers (2013) 0.91
Single nucleotide polymorphism (SNP)-based loss of heterozygosity (LOH) testing by real time PCR in patients suspect of myeloproliferative disease. PLoS One (2012) 0.84
A novel, highly sensitive and rapid allele-specific loop-mediated amplification assay for the detection of the JAK2V617F mutation in chronic myeloproliferative neoplasms. Haematologica (2012) 0.83
Melting curve analysis after T allele enrichment (MelcaTle) as a highly sensitive and reliable method for detecting the JAK2V617F mutation. PLoS One (2015) 0.75
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood (2009) 23.52
A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med (2005) 21.48
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet (2005) 18.59
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature (2005) 18.43
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell (2005) 17.41
Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem (1995) 8.52
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med (2007) 8.18
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med (2006) 7.95
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia (2009) 4.53
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia (2010) 4.09
JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia. Blood (2005) 3.24
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet (2009) 3.21
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet (2009) 3.10
A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet (2009) 3.00
Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood (2006) 2.98
Polycythemia vera is not initiated by JAK2V617F mutation. Exp Hematol (2007) 2.75
Letter: Bone-marrow responses in polycythemia vera. N Engl J Med (1974) 2.61
The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors. Leukemia (2006) 2.57
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Blood (2007) 2.53
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden. Leukemia (2007) 2.09
The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera. Cancer (2006) 1.64
Real-time PCR technology for cancer diagnostics. Clin Chem (2002) 1.61
Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino. Appl Microbiol Biotechnol (2006) 1.61
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis. Blood (2006) 1.51
JAK2(V617F): Prevalence in a large Chinese hospital population. Blood (2006) 1.50
Concordance of assays designed for the quantification of JAK2V617F: a multicenter study. Haematologica (2008) 1.33
Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia. Haematologica (2008) 1.21
A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis. Leukemia (2006) 1.20
Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders. J Mol Diagn (2007) 1.19
JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn (2006) 1.18
The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis. Mayo Clin Proc (2005) 1.17
Clinical relevance of JAK2 (V617F) mutant allele burden. Haematologica (2009) 1.09
A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD). Leuk Res (2007) 1.09
Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis. Leukemia (2006) 1.07
Clinical performance of JAK2 V617F mutation detection assays in a molecular diagnostics laboratory: evaluation of screening and quantitation methods. Am J Clin Pathol (2009) 1.01
A sensitive and reliable semi-quantitative real-time PCR assay to detect JAK2 V617F in blood. Hematol Oncol (2006) 0.99
Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation. Transplantation (2007) 0.99
JAK2 V617F in myeloid disorders: what do we know now, and where are we headed? Leuk Lymphoma (2006) 0.98
Clinical applications of cell-free fetal DNA from maternal plasma. Obstet Gynecol (2004) 0.98
Fully automated and super-rapid system for the detection of JAK2V617F mutation. Leuk Res (2008) 0.95
Detection of the JAK2(V617F) mutation in myeloproliferative disorders by melting curve analysis using the LightCycler system. Arch Pathol Lab Med (2006) 0.94
Combined locked nucleic acid and molecular beacon technologies for sensitive detection of the JAK2V617F somatic single-base sequence variant. Clin Chem (2006) 0.92
Quantitative determination of JAK2 V617F by TaqMan: An absolute measure of averaged copies per cell that may be associated with the different types of myeloproliferative disorders. J Mol Diagn (2007) 0.91
Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases. Ann Hematol (2008) 0.90
Detection of the JAK2 V617F missense mutation by high resolution melting analysis and its validation. Clin Chim Acta (2009) 0.90
Detection of the JAK2V617F mutation by asymmetric PCR and melt curve analysis. Cancer Biomark (2007) 0.86
Development of a quantitative real-time polymerase chain reaction assay for the detection of the JAK2 V617F mutation. J Mol Diagn (2007) 0.85
Two-round allele specific-polymerase chain reaction: a simple and highly sensitive method for JAK2V617F mutation detection. Clin Chim Acta (2008) 0.85
A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide. J Mol Diagn (2010) 0.83
Detection of the JAK2 V617F mutation by LightCycler PCR and probe dissociation analysis. J Mol Diagn (2006) 0.83
A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation. Am J Clin Pathol (2007) 0.82
MassARRAY assay: a more accurate method for JAK2V617F mutation detection in Chinese patients with myeloproliferative disorders. Leukemia (2007) 0.82
Comparative evaluation of three JAK2V617F mutation detection methods. Am J Clin Pathol (2007) 0.81
Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratory. J Mol Diagn (2009) 0.80
A sensitive high-throughput method to detect activating mutations of Jak2 in peripheral-blood samples. Blood (2006) 0.80
JAK2 V617F mutation detection: laboratory comparison of two kits using RFLP and qPCR. Genet Test Mol Biomarkers (2010) 0.80
Mutational analysis in BCR-ABL-negative classic myeloproliferative neoplasms: impact on prognosis and therapeutic choices. Leuk Lymphoma (2010) 0.78
Automated JAK2V617F quantification using a magnetic filtration system and sequence-specific primer-single molecule fluorescence detection. Cancer Genet Cytogenet (2007) 0.78
Quantitation of the JAK2V617F mutation in microdissected bone marrow trephines: equal mutational load in myeloid lineages and rare involvement of lymphoid cells. Am J Surg Pathol (2008) 0.77
New developments in the diagnosis of bloodstream infections. Lancet Infect Dis (2004) 3.01
Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clin Vaccine Immunol (2009) 2.35
Alarmingly poor performance in Chlamydia trachomatis point-of-care testing. Sex Transm Infect (2010) 2.16
Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol (2002) 2.06
Methicillin-resistant Staphylococcus aureus in meat products, the Netherlands. Emerg Infect Dis (2007) 1.94
Faster identification of pathogens in positive blood cultures by fluorescence in situ hybridization in routine practice. J Clin Microbiol (2006) 1.74
Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis (2012) 1.69
Interlaboratory evaluation of different extraction and real-time PCR methods for detection of Coxiella burnetii DNA in serum. J Clin Microbiol (2010) 1.65
Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol (2005) 1.60
Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. FEMS Immunol Med Microbiol (2005) 1.52
Genotypic diversity of Coxiella burnetii in the 2007-2010 Q fever outbreak episodes in The Netherlands. J Clin Microbiol (2011) 1.49
Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit. J Antimicrob Chemother (2006) 1.40
Comparison of subgingival bacterial sampling with oral lavage for detection and quantification of periodontal pathogens by real-time polymerase chain reaction. J Periodontol (2007) 1.36
Optimization of real-time PCR assay for rapid and sensitive detection of eubacterial 16S ribosomal DNA in platelet concentrates. J Clin Microbiol (2003) 1.34
Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis (2011) 1.34
The human microbiome as a reservoir of antimicrobial resistance. Front Microbiol (2013) 1.27
Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit. J Clin Microbiol (2002) 1.27
Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia. J Clin Microbiol (2009) 1.25
Comparison of real-time PCR and culture for detection of Porphyromonas gingivalis in subgingival plaque samples. J Clin Microbiol (2003) 1.25
Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis (2012) 1.24
Single-nucleotide-polymorphism genotyping of Coxiella burnetii during a Q fever outbreak in The Netherlands. Appl Environ Microbiol (2011) 1.21
Quantitative detection of Staphylococcus aureus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit. J Clin Microbiol (2007) 1.13
The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. Blood (2002) 1.12
Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol (2002) 1.11
Analysis of multiple single nucleotide polymorphisms (SNP) on DNA traces from plasma and dried blood samples. J Immunol Methods (2007) 1.06
Large-scale identification of disease genes involved in acute myeloid leukemia. J Virol (2004) 1.02
Rapid identification of pathogens in blood cultures with a modified fluorescence in situ hybridization assay. J Clin Microbiol (2006) 1.02
Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey. Int J Antimicrob Agents (2010) 1.02
A case of New Delhi metallo-β-lactamase 1 (NDM-1)-producing Klebsiella pneumoniae with putative secondary transmission from the Balkan region in the Netherlands. Antimicrob Agents Chemother (2012) 1.01
Epidemic Q fever in humans in the Netherlands. Adv Exp Med Biol (2012) 1.01
Genetic markers for Clostridium difficile lineages linked to hypervirulence. Microbiology (2011) 0.97
Evaluation of a diagnostic algorithm for acute Q fever in an outbreak setting. Clin Vaccine Immunol (2011) 0.97
Detection of bacteria in platelet concentrates: comparison of broad-range real-time 16S rDNA polymerase chain reaction and automated culturing. Transfusion (2005) 0.96
Characterization of the integrated filamentous phage Pf5 and its involvement in small-colony formation. Microbiology (2007) 0.95
Detection of bacterial DNA in blood samples from febrile patients: underestimated infection or emerging contamination? FEMS Immunol Med Microbiol (2004) 0.95
The additional value of real-time PCR in the quantitative detection of periodontal pathogens. J Clin Periodontol (2006) 0.95
High rates of antimicrobial drug resistance gene acquisition after international travel, The Netherlands. Emerg Infect Dis (2014) 0.90
Rapid detection of methicillin-resistant Staphylococcus aureus in screening samples by relative quantification between the mecA gene and the SA442 gene. J Microbiol Methods (2012) 0.88
Characteristics of clinical Helicobacter pylori strains from Ecuador. J Antimicrob Chemother (2003) 0.88
Performance of cobas® 4800 and m2000 real-time™ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in rectal and self-collected vaginal specimen. Diagn Microbiol Infect Dis (2013) 0.86
Removal of contaminating DNA from commercial nucleic acid extraction kit reagents. J Microbiol Methods (2004) 0.86
TaqMan assay for Swedish Chlamydia trachomatis variant. Emerg Infect Dis (2007) 0.85
IL-18 serum concentration is markedly elevated in acute EBV infection and can serve as a marker for disease severity. J Infect Dis (2012) 0.85
VKORC1 mutations in patients with partial resistance to phenprocoumon. Br J Haematol (2009) 0.85
Single nucleotide polymorphism (SNP)-based loss of heterozygosity (LOH) testing by real time PCR in patients suspect of myeloproliferative disease. PLoS One (2012) 0.84
Bordetella holmesii meningitis in a 12-year-old anorectic girl. Pediatr Infect Dis J (2012) 0.83
Rapid HLA-B27 screening with real-time TaqMan PCR: a clinical validation in the Dutch population. Clin Chem Lab Med (2011) 0.83
Binary IS typing for Staphylococcus aureus. PLoS One (2010) 0.83
Performance and suitability of polymerase chain reaction for early detection of bacteria in platelet concentrates. Transfusion (2011) 0.82
Detection of Helicobacter species DNA by quantitative PCR in the gastrointestinal tract of healthy individuals and of patients with inflammatory bowel disease. FEMS Immunol Med Microbiol (2004) 0.82
Detection of the JAK2V617F mutation in patients with slightly elevated platelets or hemoglobin without a secondary cause. Ann Hematol (2007) 0.82
Mannose-binding lectin in term newborns and their mothers: genotypic and phenotypic relationship. Hum Immunol (2008) 0.81
Chronic Q fever-related dual-pathogen endocarditis: case series of three patients. J Clin Microbiol (2011) 0.81
Integron class 1 reservoir among highly resistant gram-negative microorganisms recovered at a Dutch teaching hospital. Infect Control Hosp Epidemiol (2009) 0.81
Development of a reverse transcription-polymerase chain reaction assay for eubacterial RNA detection in platelet concentrates. Transfusion (2010) 0.81
Screening of post-mortem tissue donors for Coxiella burnetii infection after large outbreaks of Q fever in The Netherlands. BMC Infect Dis (2014) 0.81
Distribution, origin and contamination risk of coagulase-negative staphylococci from platelet concentrates. J Med Microbiol (2011) 0.80
Mannose-binding lectin gene polymorphisms in relation to periodontitis. J Clin Periodontol (2008) 0.79
Progressive macular hypomelanosis is associated with a putative Propionibacterium species. J Invest Dermatol (2009) 0.79
Rapid plasmid replicon typing by real time PCR melting curve analysis. BMC Microbiol (2013) 0.78
Histological characteristics of the abdominal aortic wall in patients with vascular chronic Q fever. Int J Exp Pathol (2014) 0.78
Molecular relatedness of Propionibacterium species isolated from blood products and on the skin of blood donors. Transfusion (2011) 0.78
Applications of real-time PCR in the screening of platelet concentrates for bacterial contamination. Expert Rev Mol Diagn (2006) 0.78
No human transmission of Mycobacterium malmoense in a perfect storm setting. Eur Respir J (2012) 0.78
Fructo-oligosaccharides and fibre in enteral nutrition has a beneficial influence on microbiota and gastrointestinal quality of life. Scand J Gastroenterol (2009) 0.77
Considerations in evaluating the applicability of universal detection of oral pathogens. J Clin Microbiol (2004) 0.76
Real-time amplification of HLA-DQA1 for counting residual white blood cells in filtered platelet concentrates. Transfusion (2004) 0.76
Composition and diversity of the duodenal mucosa-associated microbiome in children with untreated coeliac disease. Scand J Gastroenterol (2013) 0.76
Amplified fragment-length polymorphism analysis. Methods Mol Biol (2009) 0.76
Future diagnosis of sepsis. Lancet (2010) 0.76
Coxiella burnetii DNA in goat milk after vaccination with Coxevac(®). Vaccine (2011) 0.76
Rapid screening by real-time 16S rDNA PCR for bacterial contamination of blood products. Clin Chem Lab Med (2008) 0.75
[Resistance to coumarin derivatives due to mutated vitamin-K enzyme]. Ned Tijdschr Geneeskd (2009) 0.75
A newly identified deletion of 970 bp at the alpha-globin locus that removes the promoter region of the alpha1 gene. Hemoglobin (2006) 0.75
Septicemia, endocarditis, and cerebral infarction due to Staphylococcus aureus in a harp seal (Phoca groenlandica). J Zoo Wildl Med (2009) 0.75
Emergence of metallo-beta-lactamases in the Netherlands. J Med Microbiol (2009) 0.75